The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell lines
- PMID: 8049141
- DOI: 10.1016/0960-0760(94)90019-1
The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell lines
Abstract
The effects of 17 beta-estradiol (E2) on the growth and the levels of estrogen receptor (ER), progesterone receptor (PR) and pS2 protein were examined in a range of 8 ovarian carcinoma cell lines. E2 stimulated growth of the 3 cell lines with an ER content of 80-220 fmol/mg protein but not the 5 cell lines with ER concentrations less than 20 fmol/mg protein. After exposure to E2, ER concentration in 2 of the 3 responsive cell lines was decreased relative to untreated cells and in 2 lines, progesterone receptors were increased. No change in steroid receptor levels was observed in cell lines with low or negligible levels of receptors. The pS2 protein was not induced by E2 in the 5 ovarian carcinoma cell lines examined. These results indicate that E2 can stimulate the growth of some ER-positive ovarian carcinoma cells and that these effects may be associated with changes in the cellular levels of steroid hormone receptors.
Similar articles
-
SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens.J Steroid Biochem Mol Biol. 1995 Dec;55(3-4):279-89. doi: 10.1016/0960-0760(95)00187-5. J Steroid Biochem Mol Biol. 1995. PMID: 8541224
-
Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones.J Soc Gynecol Investig. 2001 Mar-Apr;8(2):104-13. J Soc Gynecol Investig. 2001. PMID: 11336882
-
Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.Cancer Res. 2000 Jun 15;60(12):3175-82. Cancer Res. 2000. PMID: 10866308
-
Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen.Clin Cancer Res. 1998 Sep;4(9):2245-51. Clin Cancer Res. 1998. PMID: 9748145
-
[Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].C R Seances Soc Biol Fil. 1998;192(2):241-51. C R Seances Soc Biol Fil. 1998. PMID: 9841098 Review. French.
Cited by
-
Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum.J Clin Oncol. 2017 Apr 1;35(10):1103-1111. doi: 10.1200/JCO.2016.71.0632. Epub 2017 Feb 21. J Clin Oncol. 2017. PMID: 28221866 Free PMC article.
-
Cytotoxic Activity of Novel GnRH Analogs Conjugated with Mitoxantrone in Ovarian Cancer Cells.Molecules. 2024 Aug 30;29(17):4127. doi: 10.3390/molecules29174127. Molecules. 2024. PMID: 39274973 Free PMC article.
-
Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo.Clin Cancer Res. 2012 Nov 1;18(21):5911-23. doi: 10.1158/1078-0432.CCR-12-1257. Epub 2012 Aug 15. Clin Cancer Res. 2012. PMID: 22896656 Free PMC article.
-
Insights Into the Role of Epigenetic Factors Determining the Estrogen Response in Estrogen-Positive Ovarian Cancer and Prospects of Combining Epi-Drugs With Endocrine Therapy.Front Genet. 2022 Jul 8;13:812077. doi: 10.3389/fgene.2022.812077. eCollection 2022. Front Genet. 2022. PMID: 35873467 Free PMC article. Review.
-
Increased immunostaining of fibulin-1, an estrogen-regulated protein in the stroma of human ovarian epithelial tumors.Am J Pathol. 1998 Nov;153(5):1579-88. doi: 10.1016/S0002-9440(10)65746-X. Am J Pathol. 1998. PMID: 9811350 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials